Mei Yueh Ho
Direttore/Membro del Consiglio presso KINPO ELECTRONICS, INC.
Profilo
Mei Yueh Ho is an Independent Director at Kinpo Electronics, Inc., Center Laboratories, Inc., ASE Technology Holding Co., Ltd., and Onward Therapeutics SA. She previously served as Chairman at Council For Economic Planning & Development, Independent Non-Executive Director at Ausnutria Dairy Corp.
Ltd., Independent Director at AUO Corp., Independent Director at Bank of Kaohsiung Co., Ltd., Independent Director at Taiwan Pelican Express Co., Ltd., and Minister at Ministry of Economic Affairs.
She received her undergraduate degree from National Taiwan University and her graduate degree from National Chengchi University.
Posizioni attive di Mei Yueh Ho
| Società | Posizione | Inizio |
|---|---|---|
| KINPO ELECTRONICS, INC. | Direttore/Membro del Consiglio | 13/06/2013 |
| ASE TECHNOLOGY HOLDING CO., LTD. | Direttore/Membro del Consiglio | 21/06/2018 |
| CENTER LABORATORIES, INC. | Direttore/Membro del Consiglio | 24/06/2020 |
Onward Therapeutics SA
 Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mei Yueh Ho
| Società | Posizione | Fine |
|---|---|---|
| AUO CORPORATION | Direttore/Membro del Consiglio | 17/06/2022 |
| AUSNUTRIA DAIRY CORPORATION LTD | Direttore/Membro del Consiglio | 06/12/2018 |
| TAIWAN PELICAN EXPRESS CO., LTD. | Direttore/Membro del Consiglio | 01/05/2015 |
| Council For Economic Planning & Development | Presidente | 01/05/2008 |
| Ministry of Economic Affairs | Corporate Officer/Principal | 01/01/2006 |
Formazione di Mei Yueh Ho
| National Taiwan University | Undergraduate Degree |
| National Chengchi University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 7 |
|---|---|
| AUO CORPORATION | Electronic Technology |
| BANK OF KAOHSIUNG CO., LTD. | Finance |
| TAIWAN PELICAN EXPRESS CO., LTD. | Transportation |
| KINPO ELECTRONICS, INC. | Electronic Technology |
| AUSNUTRIA DAIRY CORPORATION LTD | Consumer Non-Durables |
| ASE TECHNOLOGY HOLDING CO., LTD. | Electronic Technology |
| CENTER LABORATORIES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Advanced Semiconductor Engineering, Inc.
 Advanced Semiconductor Engineering, Inc. SemiconductorsElectronic Technology Advanced Semiconductor Engineering, Inc. engages in the provision of independent semiconductor manufacturing services. It operates through the following segments: Packaging, Testing, and Electronic Manufacturing Services (EMS). The Packaging segment involves in the production of bare semiconductors into finished semiconductors with electrical and thermal characteristics. The Testing segment offers front-end engineering testing, wafer probing and final testing services. The EMS segment designs, assembles, and markets electronic components and telecommunications equipment motherboards. The company was founded by Chien Shen Chang and Hung Pen Chang on March 23, 1984 and is headquartered in Kaohsiung, Taiwan. | Electronic Technology |
| Council For Economic Planning & Development | Government |
Onward Therapeutics SA
Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Health Technology |
| Ministry of Economic Affairs |
- Borsa valori
- Insiders
- Mei Yueh Ho
